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Abstract  
Alimentary products of medicinal Lucilia sericata larvae are studied to determine their 
mechanisms of action, particularly in the contexts of wound debridement and disinfection. 
Furthermore, the larvae can be applied to patients in contained devices, such as the BioBag 
(BioMonde). Here, we tested the materials and larval content of the most commonly used 
BioBag (the “BB-50”) to explore the possibility that endotoxins may be contributing to the bio-
activity of the product, given that endotoxins are potent stimulants of cellular activation. Using 
standardised protocols to collect larval alimentary products (LAP), we proceeded to determine 
residual endotoxin levels in LAP derived from the BioBag, before and after the neutralisation 
Pickles & Pritchard (2017)  Wound Repair Regen 2 
 
of interfering enzymatic activity. The BB-50 device and its associated larval content was not a 
significant source of LPS activity. However, it is clear from these experiments that a failure to 
remove the confounding serine proteinase activity would have resulted in spuriously high and 
erroneous results. The residual LPS levels detected are unlikely to be active in wound healing 
assays, following cross-referencing to publications where LPS at much higher levels has been 
shown to have positive and negative effects on processes associated with wound repair and 
tissue regeneration. 
 
Introduction 
The BioBag (BioMonde), a medicinal product containing larvae of the greenbottle blow-
fly Lucilia sericata, debrides and disinfects chronic wounds (1, 2). However, the molecular 
basis for its bio-activity is not yet fully understood. Although enzymes (serine proteinases, 
DNAse, glycosidases) are strongly implicated in the debridement activity of the product, 
and in the promotion of fibroblast motogenesis, and a defined antibiotic (Lucifensin) has 
been identified (3) little is known of other factors which may be present in relation to wound 
repair and regeneration. 
In the present study, we begin to explore the scenario that symbiont-derived 
endotoxin/lipopolysaccharide (LPS) in larval alimentary products (LAP) from larvae within 
BioBags could, if present, have a downstream effect on cell behaviour in wound-healing 
assays, given the potent stimulatory effects of LPS on cell activation (4, 5). 
Lipopolysaccharide arises from the outer membrane of Gram-negative bacteria; species of 
which are known to be harboured by Lucilia sericata larvae as symbionts (6). 
To detect the presence of authentic endotoxin activity, we used the Limulus amoebocyte 
lysate (LAL) chromogenic assay. As this, and other tests for LPS, is subject to interference 
by serine proteases (7), it was necessary to prove that we had first denatured those known to 
be endogenous to LAP (8, 9) using heat-treatment and the recently-developed radial diffusion 
enzymatic assay (RDEA) (10). 
Once this was successfully achieved, it was then possible to demonstrate clearly that the 
BioBag was devoid of significant authentic endotoxin activity. However, future 
investigators should be wary that residual LPS levels could compromise the interpretation 
of data pertaining to the wound-healing attributes of LAP in cellular assays associated with 
wound repair and regeneration, unless other steps had first been taken to identify the active 
ingredient (11). Based on our findings, we would recommend routine testing for endotoxin 
activity prior to any cell-based wound-healing assay utilising LAP, and guide the reader to 
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protocols designed to remove residual activity. This recommendation is particularly relevant 
in situations where larvae have been obtained from unregulated sources, and LAP collected 
using reagents and consumables which have not been certified as endotoxin-free. 
 
Materials and Methods 
All material was handled inside a Class II microbiological safety cabinet unless otherwise 
stated. All reagents and consumables were obtained from Sigma-Aldrich unless otherwise 
stated, certified as endotoxin-free and unopened before use. 
 
Preparation of larval alimentary products (LAP) 
Larval alimentary products were collected from six sterile BB-50 debridement devices (2.5 
× 4 cm) as supplied by BioMonde (Bridgend, UK) under the standardised conditions as 
described previously (10) using 2.5 mL sterile PBS (phosphate-buffered saline). Aliquots of 
LAP solution (200 μL) from individual BioBags were prepared for testing, in duplicate pairs 
of native and heat-treated material (90oC for 10 minutes). Aliquots from the control devices 
were not heat-treated. 
 
Enzyme assay 
The existing and subsequently denatured gelatinase activity of LAP was determined using 
the radial-diffusion enzyme (RDEA) system in duplicate, as detailed previously (10). The 
system buffer, TBS (tris-buffered saline) was utilised as a blank sample, and a positive 10 
mg/mL collagenase (gelatinase) control was prepared from Clostridium histolyticum (Type 
VII) in TBS. Plates were incubated for 6 hours at 37oC, prior to fixation for 30 minutes (acetic 
acid, methanol and water; 10:25:65) at room temperature. Gels were stained within the assay 
plates using 0.05% Coomassie Brilliant Blue R-250 to confirm protein digestion. 
Gel plates were photographed at a fixed height on a transmitted light-box with calibrated 
scale and processed using ImageJ software (v.1.41o, National Institutes of Health; Maryland, 
USA). Images were calibrated against the scale in each 8-bit (greyscale) image, and gelatinase 
activity was determined by measuring each halo (area of digestion, mm2), and corrected by 
subtracting the area of the test well. 
 
Endotoxin assay 
Endotoxin quantification was undertaken using a chromogenic Limulus amoebocyte lysate 
(LAL) assay kit (Pierce; Illinois, USA). Test samples and standards were prepared according 
to manufacturer’s guidelines, and modified for incubation using 1.5 mL centrifuge tubes. 
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Absorbance was measured at 405 nm using Tecan Spark 10M microplate-reader (Grödig, 
Austria). Data were corrected to exclude background readings, and the values obtained as 
endotoxin units (EU/mL; one EU/mL equals approximately 0.1 ng endotoxin/mL) for each 
test sample were interpolated using the standard curve produced for each assay replicate. 
Endotoxin content per device (EU/device) was extrapolated, based on the elution volume of 
2.5 mL PBS. 
 
Data analysis  
All data were analysed using GraphPad Prism (v.7.01; California, USA) and normality 
was examined using the Shapiro-Wilk test. Gelatinase activity is expressed as the mean 
halo/digestion area (mm2, in duplicate) with standard deviation ( SD). Endotoxin presence 
is expressed as mean endotoxin units per device (EU/device; n=2,  SD), following elution 
in 2.5 mL of buffer. The statistical significance of LAP-denaturation on the LAL assay was 
determined using the Wilcoxon matched-pairs signed rank test; a probability value (P) of < 
0.05 was considered significant. 
 
Results 
Prior to heat-treatment, LAP from all larval loaded BioBags (n=6) demonstrated 
gelatinase activity with a mean digestion halo area of 80.8  6.66 mm2. Control devices did 
not produce any digestion halos (Figure 1a). Confirmation of enzyme denaturation was 
achieved following the complete removal of the initial activity, as demonstrated by the before 
and after test wells (Figure 1b). 
 
Figure 1. (a) Gelatinase activity of individual devices determined by the RDEA assay (mean ± SD, n=2 
replicates), for larval loaded devices (BB) and control materials (C). Positive collagenase (+ve) and negative 
TBS buffer (-ve) controls are included. (b) Visual confirmation of existing gelatinase activity (1–6) and 
subsequent denaturation by heat (1H), against TBS blank (7) and collagenase positive control (8). Scale bar, 10 
mm. 
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Prior to heat-treatment, LAP from all larval loaded BioBags (n=6) tested positive for the 
presence of endotoxins, with a mean value of 1.62  0.29 EU/device. Following enzymatic 
denaturation, each LAP sample remained positive, but with a reduction of 24 - 60% 
throughout the group (Figure 2a), resulting in a mean value of 0.92  0.36 EU/device. The 
difference between the two sample groups was determined to be statistically significant (P = 
0.031). Control devices were not heat-treated and a background level of 0.15  0.02 
EU/device was recorded throughout (Figure 2b). The residual levels of LPS detected 
following enzymatic neutralisation (0.04 ng/mL after conversion from EU/mL) indicate that 
the device is medically benign (12) in terms of contributing LPS- mediated effects to the wound 
environment.  
 
Figure 2. (a) Endotoxin content of individually eluted larval loaded devices (BB), as determined by the LAL 
assay (mean ± SD, n=2 replicates), for native material and following the denaturation of enzyme activity by heat 
(+H). (b) Mean endotoxin content of loaded devices before and after enzyme denaturation by heat (+H), as 
compared with control materials. Statistical significance * (P = 0.031) determined using Wilcoxon matched-
pairs signed rank test (n=6 devices, in duplicate ± SD). Following heating, the residual mean endotoxin value 
was 0.92 EU/device. Prior to heating, confounding enzyme activity would have contributed to a spuriously 
elevated reading. One endotoxin unit/ml (EU/ml) equals approximately 0.1 ng endotoxin/ml of solution. 
 
 
 
These levels are also unlikely to be of biological significance ex vivo as they are well 
below the levels shown to elicit effects in assays for wound healing (10 μg/mL) (4) and tissue 
regeneration (10 ng/mL) (5). However, investigators using larvae and LAP from unregulated 
sources are advised to be suitably cautious, as discussed below. 
 
Discussion  
The present study was conducted to determine whether larvae contained within the BB-50 
device, used as an active debridement agent, produced LPS; a bio-active molecule which 
interfere with assays pertaining to wound repair and regeneration. It would appear from this 
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study that LPS is not a major component of LAP emanating from this device; however, a 
failure to take into account the serine proteinase activity associated with the LAP would have 
led to spuriously high and erroneous endotoxin values. It should be noted that the brief heat-
treatment applied to LAP for enzymatic denaturation (90oC for 10 minutes) is not adequate 
for depyrogenation, which requires sustained periods in temperatures in excess of 200oC (13). 
Therefore, we report authentic endotoxin values, which have not been subjected to interference 
during the protocol. Furthermore, as the majority of endotoxin screening assays involve the 
enzymatic cleavage of a substrate and LAP is known to possess a range of enzyme classes, (8, 
9, 14, 15) it is recommended that an effective denaturation step is incorporated during testing, for 
comparative purposes. 
The data presented here will inform scientists performing experiments using LAP of the 
potential for LPS-mediated confounding effects on cellular behaviour, particularly where the 
effects seen were not neutralised by other means, such as the inhibition of larval enzyme-
mediated stimulatory effects on fibroblast migration by soy bean trypsin inhibitor (11). In cases 
where there may be concern that the presence of authentic endotoxin may result in 
confounding effects, well-documented measures to remove LPS (such as affinity 
chromatography) should be taken (16). This may be particularly true for larvae (and their 
products) obtained for experimentation from non-regulated sources. In this case, all larval 
material should be subjected to routine testing for endotoxin activity, to avoid the possibility 
of generating spurious experimental data.  
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